REPORT ID 2857

China Paclitaxel Injection Market Research Report 2017

Publish Date
11-Dec-17
Pages
106
Format
Electronic (PDF)

The global Paclitaxel Injection market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Paclitaxel Injection development status and future trend in China, focuses on top players in China, also splits Paclitaxel Injection by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Bristol-Myers Squibb
    Celgene Corporation
    Hospira
    Biological E.
    Taj Accura
    Khandelwal Laboratories
    Luye Pharma
    Beijing Youcare
    Beijing Union
    Haiyao
    Chuntch

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (L), revenue (Million USD), product price (USD/L), market share and growth rate of each type, primarily split into
    30 mg/5 mL
    60 mg/10 mL
    100 mg/16.7 mL
    150 mg/25 mL
    300 mg/50 mL

On the basis of the end users/application, this report covers
    Ovarian Cancer
    Breast Cancer
    Cervical Cancer
    Pancreatic Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Paclitaxel Injection Market Research Report 2017
1 Paclitaxel Injection Overview
    1.1 Product Overview and Scope of Paclitaxel Injection
    1.2 Classification of Paclitaxel Injection by Product Category
        1.2.1 China Paclitaxel Injection Sales (L) Comparison by Type (2012-2022)
        1.2.2 China Paclitaxel Injection Sales (L) Market Share by Type in 2016
        1.2.3 30 mg/5 mL
        1.2.4 60 mg/10 mL
        1.2.5 100 mg/16.7 mL
        1.2.6 150 mg/25 mL
        1.2.7 300 mg/50 mL
    1.3 China Paclitaxel Injection Market by Application/End Users
        1.3.1 China Paclitaxel Injection Sales (L) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Ovarian Cancer
        1.3.3 Breast Cancer
        1.3.4 Cervical Cancer
        1.3.5 Pancreatic Cancer
        1.3.6 Others
    1.4 China Paclitaxel Injection Market by Region
        1.4.1 China Paclitaxel Injection Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Paclitaxel Injection Status and Prospect (2012-2022)
        1.4.3 East China Paclitaxel Injection Status and Prospect (2012-2022)
        1.4.4 Southwest China Paclitaxel Injection Status and Prospect (2012-2022)
        1.4.5 Northeast China Paclitaxel Injection Status and Prospect (2012-2022)
        1.4.6 North China Paclitaxel Injection Status and Prospect (2012-2022)
        1.4.7 Central China Paclitaxel Injection Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Paclitaxel Injection (2012-2022)
        1.5.1 China Paclitaxel Injection Sales (L) and Growth Rate (%)(2012-2022)
        1.5.2 China Paclitaxel Injection Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Paclitaxel Injection Market Competition by Players/Manufacturers
    2.1 China Paclitaxel Injection Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Paclitaxel Injection Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Paclitaxel Injection Average Price (USD/L) by Players/Manufacturers (2012-2017)
    2.4 China Paclitaxel Injection Market Competitive Situation and Trends
        2.4.1 China Paclitaxel Injection Market Concentration Rate
        2.4.2 China Paclitaxel Injection Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Paclitaxel Injection Manufacturing Base Distribution, Sales Area, Product Types

3 China Paclitaxel Injection Sales and Revenue by Region (2012-2017)
    3.1 China Paclitaxel Injection Sales (L) and Market Share by Region (2012-2017)
    3.2 China Paclitaxel Injection Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Paclitaxel Injection Price (USD/L) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Paclitaxel Injection Sales (L) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Paclitaxel Injection Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Paclitaxel Injection Price (USD/L) by Type (2012-2017)
    4.4 China Paclitaxel Injection Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Paclitaxel Injection Sales (L) and Market Share by Application (2012-2017)
    5.2 China Paclitaxel Injection Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Paclitaxel Injection Players/Suppliers Profiles and Sales Data
    6.1 Bristol-Myers Squibb
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Paclitaxel Injection Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Celgene Corporation
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Paclitaxel Injection Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Celgene Corporation Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Hospira
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Paclitaxel Injection Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Hospira Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Biological E.
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Paclitaxel Injection Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Biological E. Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Taj Accura
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Paclitaxel Injection Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Taj Accura Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Khandelwal Laboratories
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Paclitaxel Injection Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Khandelwal Laboratories Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Luye Pharma
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Paclitaxel Injection Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Luye Pharma Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Beijing Youcare
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Paclitaxel Injection Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Beijing Youcare Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Beijing Union
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Paclitaxel Injection Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Beijing Union Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Haiyao
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Paclitaxel Injection Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Haiyao Paclitaxel Injection Sales (L), Revenue (Million USD), Price (USD/L) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Chuntch

7 Paclitaxel Injection Manufacturing Cost Analysis
    7.1 Paclitaxel Injection Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Paclitaxel Injection

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Paclitaxel Injection Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Paclitaxel Injection Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Paclitaxel Injection Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Paclitaxel Injection Sales (L), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Paclitaxel Injection Sales (L) Forecast by Type (2017-2022)
    11.3 China Paclitaxel Injection Sales (L) Forecast by Application (2017-2022)
    11.4 China Paclitaxel Injection Sales (L) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List